Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.490
-0.150 (-4.12%)
At close: Apr 1, 2025, 4:00 PM
3.492
+0.002 (0.05%)
After-hours: Apr 1, 2025, 4:50 PM EDT

Qualigen Therapeutics Market Cap

Qualigen Therapeutics has a market cap or net worth of $2.57 million as of April 1, 2025. Its market cap has increased by 28.51% in one year.

Market Cap
2.57M
Enterprise Value
3.73M
1-Year Change
28.51%
Ranking
Category
Stock Price
$3.49

Market Cap Chart

Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.40M to $2.57M, a decrease of -93.31%. That is a compound annual growth rate of -24.18%.

History

DateMarket Cap% Change
Mar 28, 20252.80M-9.68%
Dec 31, 20243.10M10.71%
Dec 29, 20232.80M-48.15%
Dec 30, 20225.40M-82.69%
Dec 31, 202131.20M-55.04%
Dec 31, 202069.40M3,982.35%
Dec 31, 20191.70M-50.00%
Dec 31, 20183.40M-79.14%
Dec 29, 201716.30M-43.99%
Dec 30, 201629.10M120.45%
Dec 31, 201513.20M-65.63%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 720.58B
UnitedHealth Group 475.91B
Johnson & Johnson 397.94B
AbbVie 366.14B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 227.21B
Merck & Co. 223.66B
Market Cap Rankings